Artículo
Single-Channel Kinetic Analysis of Chimeric 7-5HT3A Receptors
Fecha de publicación:
08/2005
Editorial:
American Society for Pharmacology and Experimental Therapeutics
Revista:
Molecular Pharmacology
ISSN:
0026-895
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
The receptor chimera 7–5HT3A has served as a prototype for understanding the pharmacology of 7 neuronal nicotinic receptors, yet its low single channel conductance has prevented studies of the activation kinetics of single receptor channels. In this study, we show that introducing mutations in the M3–M4 cytoplasmic linker of the chimera alters neither the apparent affinity for the agonist nor the EC50 but increases the amplitude of agonist-evoked single channel currents to enable kinetic analysis. Channel events appear as single brief openings flanked by long closings or as bursts of several openings in quick succession. Both the open and closed time distributions are described as the sum of multiple exponential components, but these do not change over a wide range of acetylcholine (ACh), nicotine, or choline concentrations. Bursts elicited by a saturating concentration of ACh contain brief and long openings and closings, and a cyclic scheme containing two open and two closed states is found to adequately describe the data. The analysis indicates that once fully occupied, the receptor opens rapidly and efficiently, and closes and reopens several times before it desensitizes. Channel closing and desensitization occur at similar rates and account for the invariant open and closed time distributions.
Palabras clave:
Nicotinic
,
Receptor
,
Activation
,
Homomeric
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(INIBIBB)
Articulos de INST.DE INVEST.BIOQUIMICAS BAHIA BLANCA (I)
Articulos de INST.DE INVEST.BIOQUIMICAS BAHIA BLANCA (I)
Citación
Rayes, Diego Hernán; Spitzmaul, Guillermo Federico; Sine, Steven M.; Bouzat, Cecilia Beatriz; Single-Channel Kinetic Analysis of Chimeric 7-5HT3A Receptors; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 68; 5; 8-2005; 1475-1483
Compartir
Altmétricas